FRANKLIN LAKES, N.J., Jan. 12, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will host its virtual 2026 Annual Meeting of
Original sourceBD (Becton, Dickinson and Company) is holding its virtual 2026 Annual Meeting on January 27, offering shareholders the opportunity to engage and vote. This transparency may enhance investor confidence in BDX's commitment to stakeholder engagement and growth strategies, potentially impacting stock performance positively.
Enhanced shareholder engagement and potential positive outcomes from the meeting may increase stock demand, similar to past meetings that generated positive investor responses.
Consider accumulating BDX shares in anticipation of positive shareholder feedback post-meeting.
This news fits under 'Corporate Developments' as it involves shareholder engagement and opens up potential discussions about future company direction, which can influence investor perceptions and stock performance.
FRANKLIN LAKES, N.J., Jan. 12, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will host its virtual 2026 Annual Meeting of Shareholders (the "Annual Meeting") on Tuesday, January 27, 2026, at 1:00 p.m. (ET).
As described in the proxy materials for the Annual Meeting previously distributed, shareholders as of the close of business on December 8, 2025, or their duly authorized proxies, will be able to attend and participate in the Annual Meeting, vote their shares and ask questions by visiting https://meetnow.global/MFT7Y46. Guests may also access the Annual Meeting but in listen-only mode. No control number is required for guests.
A replay of the webcast will be available shortly after the Annual Meeting on the BD website at investors.bd.com for approximately one year from the date of the Annual Meeting.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media: | Investors: |
Fallon McLoughlin | Adam Reiffe |
Director, Public Relations | Vice President, Investor Relations |
201.258.0361 | 201.847.6927 |
View original content:https://www.prnewswire.com/news-releases/bd-to-host-virtual-2026-annual-meeting-of-shareholders-302658834.html
SOURCE BD (Becton, Dickinson and Company)